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Abstract
A wide spectrum of susceptibility and severity of infection has
been observed among COVID-19 patients. While some
individuals remain unaffected by the Sars-Cov-2 virus, others
have contracted the virus multiple times with varying levels of
severity. This poster reviews some of the research
demonstrating a link between the susceptibility of the Sars-Cov2 virus and the severity of infection, and a specific gene called
ACE2. The ACE2 gene encodes an angiotensin-converting
enzyme that acts as a functional receptor for the spike
glycoprotein receptor binding domain of the coronavirus and
severe acute respiratory syndrome coronaviruses. ACE2
presents numerous amino acid variants with different functions
and catalytic properties. The Sars-Cov-2 virus utilizes the ACE2
gene as a host receptor to infect its human host through three
amino acid (AA) residues (T20, Y83, and K353) near the
interface. Recent single-cell RNA sequencing has found organand cell-specific expression of the converting enzyme in the
lungs and alveolar tissue, explaining why infection typically
includes respiratory symptoms. It is hypothesized that
expression levels from the ACE2 gene may affect an
individual’s susceptibility to the virus and the severity of the
infection. Awareness of genetic predisposition factors can
contribute to evidence-based risk assessment which could allow
for future individualized treatments and preventative measures.

Figure 3. Percentages of positive COVID-19 cases with respect to age. Severity levels and
their trends based on age are shown by the blue, green, red, and black lines. The thin black line
reports the fraction of seropositive for each age class, which is used as the normalization for
the fractions reported in the figures. Figure from Bastolla et al. (2022).
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Figure 2. ACE2 expression location in organs associated with
COVID symptoms. Adapted from Salamanna et al. (2020).

ACE2 Mechanism of Expression and COVID-19

Figure 1. Mechanism of entry by Sars-Cov-2 virus into the host cell via
the binding site of Sars-Cov-2 spike protein and the ACE2 receptor.

The ACE2 gene encodes the host receptor that Sars-Cov2 uses to enter a human cell. Organs and tissues where
ACE2 is expressed are susceptible to the Sars-Cov-2
virus. ACE2 also encodes an enzyme that converts the
angiotensin hormones Ang I and Ang II to Ang (1–9) and
Ang (1–7) and plays a role in regulating the reninangiotensin system (RAS) responsible for homeostatic
regulation of vascular functioning. However, Sars-Cov-2
binds to ACE2 and blocks the ability of angiotensin to
bind to ACE2, throwing the RAS out of balance.
Research has revealed a correlation between low ACE2
gene expression and increased severity of COVID-19
cases. Patients with low ACE2 expression have a gene
that is downregulated. When ACE2 is downregulated, it
may be unable to bind to Sars-Cov-2 and maintain
balance of the RAS due to a slower rate of physiological
response. High expression means that the gene
is upregulated and may be able to bind to Sars-Cov-2
while keeping the RAS balanced, leading to more
successful coronavirus recoveries/outcomes.

Figure 4. Model of ACE2 levels of mRNA,
protein in the cellular membrane and protein
in serum at different ages. Figure from
Bastolla et al. (2022).
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